BridgeBio Pharma (BBIO) PT Raised to $64 at Mizuho
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $79.89 --0%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 9
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 9
Join SI Premium – FREE
Mizuho analyst Salim Syed raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $64.00 (from $60.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Berenberg Downgrades PolyPeptide Group AG (PPGN:SW) to Hold
- Nordea Bank Abp (NDA:SS) (NRDBY) PT Raised to SEK167 at JPMorgan
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
